Job Details
Description
Cimple Biotechnology Limited, a pioneering biotech firm spun off from the HK Tech 300 of CityUHK, Incu-Bio Programme of Hong Kong Science & Technology Parks Corporation and Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE), is at the forefront of innovation. Our founders, comprising Ph.D.s with extensive R&D experience in biosensing, are complemented by a team with expertise in R&D, production, and sales within the in vitro diagnostics (IVD) industry. Furthermore, our advisory board consists of medical professionals from the University of Hong Kong and the Chinese University of Hong Kong, as well as executives from leading global IVD companies. For more details, please visit www.cimple.com.hk.
Responsibilities
- Participate in formulating the company’s overall strategy and annual business plan, responsible for establishing and optimizing the end‑to‑end operation system from R&D to production.
- Oversee product line planning and technology roadmap development in the POCT field, based on an R&D or production background, deeply engage in the entire process of product development, process scale‑up, performance verification, and post‑market improvements to ensure technical leadership and product competitiveness.
- Maintain a thorough understanding of industry trends, regulatory and policy changes, and the competitive landscape in the in‑vitro diagnostics (IVD) sector, provide key input for product positioning, market strategies, and investment/financing decisions, assist in connecting with external cooperation resources.
Requirements
- Full‑time bachelor’s degree or above in Biomedical Engineering, Biotechnology, Chemistry, Pharmaceutical Engineering, or a related field.
- Familiar with medical device/IVD‑related regulations (e.g., ISO 13485, GMP) and possess practical experience in system building, supply chain management, cost control, and team management.
- 10+ years of work experience in the IVD industry, with at least 5 years in R&D, production, or operations management in the POCT field, and experience in full‑cycle management of a complete product line from R&D to market launch.
- Preference will be given to candidates who possess a valid Hong Kong work visa.
About the Company
Overview
Cimple Biotechnology Limited (Cimple), a pioneering biotech firm spun off from the HK Tech 300 of CityUHK, Incu-Bio Programme of Hong Kong Science & Technology Parks Corporation (HKSTP) and Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE), is at the forefront of innovation. We've developed a quantitative rapid test platform capable of measuring a wide range of targets, including proteins and enzyme activity. The biological marker levels are converted into visible strip lengths on the chip, readable by the naked eye or recordable via the accompanying app. Our founders, comprising Ph.D.s with extensive R&D experience in biosensing, are complemented by a team with expertise in R&D, production, and sales within the in vitro diagnostics (IVD) industry.